RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Fluoxetine

Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, Panic Disorder, Depressive Episodes associated with Bipolar I Disorder (in combination with olanzapine), Treatment Resistant Depression (in combination with olanzapine)

Boxed warning

  • WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older [see Warnings and Precautions (5.1) ] . In patients of all ages who are started on antidepressant therapy, monitor closely ... (see full label)

Indications

  • Major Depressive Disorder
  • Obsessive Compulsive Disorder
  • Bulimia Nervosa
  • Panic Disorder
  • Depressive Episodes associated with Bipolar I Disorder (in combination with olanzapine)
  • Treatment Resistant Depression (in combination with olanzapine)

Adult dosing

  • mdd: dose: 20; unit: mg; route: PO; interval: 20 to 80 mg/day once daily or divided; fixed: true; labelExcerpt: Initiate fluoxetine 20 mg/day orally in the morning. Consider a dose increase after several weeks if insufficient clinical improvement is observed. Administer doses above 20 mg/day once daily in the morning or twice daily (i.e., morning and noon). The maximum fluoxetine dose should not exceed 80 mg/day.
  • ocd: dose: 20; unit: mg; route: PO; interval: 20 to 60 mg/day once daily or divided; fixed: true; labelExcerpt: Initiate fluoxetine 20 mg/day, orally in the morning. Consider a dose increase after several weeks if insufficient clinical improvement is observed. The full therapeutic effect may be delayed until 5 weeks of treatment or longer. Administer doses above 20 mg/day once daily in the morning or twice daily
  • bulimia nervosa: dose: 60; unit: mg; route: PO; interval: 60 mg/day once daily; fixed: true; labelExcerpt: Administer fluoxetine 60 mg/day in the morning. For some patients it may be advisable to titrate up to this target dose over several days. Fluoxetine doses above 60 mg/day have not been systematically studied in patients with bulimia.
  • panic disorder: dose: 10; unit: mg; route: PO; interval: 10 to 60 mg/day once daily; fixed: true; labelExcerpt: Initiate treatment with fluoxetine 10 mg/day. After one week, increase the dose to 20 mg/day. Consider a dose increase after several weeks if no clinical improvement is observed. Fluoxetine doses above 60 mg/day have not been systematically evaluated in patients with Panic Disorder.

Pediatric dosing

  • mdd: dose: 10; unit: mg; route: PO; interval: 10 to 20 mg/day; fixed: true; labelExcerpt: Initiate Fluoxetine 10 mg/day or 20 mg/day. After 1 week at 10 mg/day, increase the dose to 20 mg/day. However, due to higher plasma levels in lower weight children, the starting and target dose in this group may be 10 mg/day. Consider a dose increase to 20 mg/day after several weeks if insufficient
  • ocd: dose: 10; unit: mg; route: PO; interval: 10 to 60 mg/day (varies by weight); fixed: true; labelExcerpt: In adolescents and higher weight children, initiate treatment with a dose of 10 mg/day. After 2 weeks, increase the dose to 20mg/day. Consider additional dose increases after several more weeks if insufficient clinical improvement is observed. A dose range of 20 mg/day to 60 mg/day is recommended.

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Lower or less frequent dosage recommended.

Contraindications

  • MAOIs (within 14 days before or 5 weeks after)
  • Linezolid or IV methylene blue
  • Pimozide
  • Thioridazine

Clinical pearls

  • Monitor for worsening depression and emergent suicidal thoughts, especially in children and young adults.
  • Potential risk for Serotonin Syndrome; caution when combining with other serotonergic agents.
  • Monitor height and weight periodically in pediatric patients due to potential decreased weight gain.
  • Long half-life means dose changes are not fully reflected in plasma for several weeks.

Source and review

  • DailyMed label (fluoxetine hydrochloride, Fluoxetine), Set ID 3d5d03ff-0d0c-429f-b747-31ff3465d39d, effective 2026-10-30. Last reviewed: 2026-11-11